FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38703911000001103: Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jul 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1464971000001114 Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1464981000001111 Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has VMP Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has specific active ingredient Potassium bicarbonate true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has specific active ingredient Sodium alginate true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has VMP Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has VMP Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gaviscon Advance oral suspension aniseed (Reckitt Benckiser Healthcare (UK) Ltd) 600 ml Is a True Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free 600 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start